The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1253
ISSUE1253
January 29, 2007
Pioglitazone/Glimepiride (Duetact) for Diabetes
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Pioglitazone/Glimepiride (Duetact) for Diabetes
January 29, 2007 (Issue: 1253)
Duetact (Takeda), a new fixed-dose combination of the thiazolidinedione pioglitazone (Actos) and the sulfonylurea glimepiride (Amaryl, and others), was recently approved by the FDA for treatment of type 2 diabetes. It is approved as an adjunct to...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.